
Business Engineering Corporation (B-EN-G) announced the launch of "BatchLine Lite MES," a cloud-based solution developed by BatchLine Inc. in Thailand, starting in March 2025. This service aims to replace traditional paper-based pharmaceutical manufacturing records with digital systems, thereby improving operational efficiency and ensuring compliance with strict industry regulations.
In the pharmaceutical industry, handwritten manufacturing records remain common, leading to frequent issues such as transcription errors, heavy review workloads, and audit complications. While Manufacturing Execution Systems (MES) are considered an ideal solution, many companies have hesitated to adopt them due to high costs and operational complexity.
BatchLine Lite MES addresses these challenges by offering a cloud-based SaaS model that is easy to implement and quick to launch. Leveraging its extensive experience in the pharmaceutical sector, B-EN-G supports companies that seek cost-effective and reliable digital transformation.
With BatchLine, companies can monitor production in real time, automate data collection through device integration, and improve both quality control and operational efficiency. These capabilities are especially valuable in a highly regulated industry that demands strict compliance with GMP and data integrity standards.
B-EN-G plans to expand the use of BatchLine across various pharmaceutical manufacturing processes, including formulation and packaging, helping the industry enhance quality and accelerate its digital transformation.
source : https://www.xpley.com/ja/news/news206